Medicofarma Biotech SA (WSE:MDB)
Poland · Delayed Price · Currency is PLN 0.3920
+0.0040 (1.03%)
At close: Aug 14, 2026
Medicofarma Biotech Balance Sheet
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 0 | 0.01 | 0.01 | 0.51 | 0.08 |
Short-Term Investments | 0 | - | - | - | - | - |
Cash & Short-Term Investments | 0 | 0 | 0.01 | 0.01 | 0.51 | 0.08 |
Cash Growth | 10.99% | -72.08% | 19.22% | -98.97% | 556.50% | 20.91% |
Accounts Receivable | 0.41 | 1.45 | 0.48 | 0.38 | 0.37 | 1.42 |
Other Receivables | 3.69 | 3.67 | 3.33 | 2.13 | 1.24 | 0.03 |
Receivables | 4.1 | 5.11 | 3.8 | 2.51 | 1.61 | 1.45 |
Inventory | - | - | 0 | 0 | 0.14 | 0.56 |
Total Current Assets | 4.1 | 5.11 | 3.81 | 2.52 | 2.26 | 2.08 |
Property, Plant & Equipment | 8.66 | 9.03 | 10.55 | 12.09 | 12.56 | 12.7 |
Other Intangible Assets | 0.03 | 0.05 | 0.1 | 0.15 | 1.54 | 1.98 |
Long-Term Deferred Tax Assets | - | - | 0.24 | 0.21 | - | - |
Other Long-Term Assets | 1.04 | 0.01 | 0.01 | - | 0.01 | - |
Total Assets | 13.84 | 14.2 | 14.71 | 14.97 | 16.37 | 16.77 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | - | 1.22 | 1.29 | 1.19 | 1.34 | 1.47 |
Accrued Expenses | 0.28 | 0.48 | 1.56 | 2.26 | 1.11 | 0.44 |
Short-Term Debt | - | 0 | 0 | 0 | - | - |
Current Income Taxes Payable | - | 2.23 | 1.5 | 0.53 | 0.14 | 0.06 |
Other Current Liabilities | 4.34 | 0.15 | 0.13 | 0.04 | 0.69 | 0.12 |
Total Current Liabilities | 4.63 | 4.09 | 4.49 | 4.02 | 3.28 | 2.08 |
Long-Term Debt | 3.91 | 3.71 | 2.53 | 1.39 | - | - |
Other Long-Term Liabilities | 0.19 | 0.72 | 0.82 | 0.38 | 0.48 | 0.48 |
Total Liabilities | 8.73 | 8.52 | 7.84 | 5.8 | 3.76 | 2.56 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 6.8 | 6.8 | 6.8 | 6.8 | 6.8 | 6.8 |
Additional Paid-In Capital | 8.95 | 8.95 | 8.95 | 8.95 | 8.95 | 8.95 |
Retained Earnings | -10.64 | -10.06 | -8.87 | -6.57 | -3.13 | -1.54 |
Shareholders' Equity | 5.11 | 5.68 | 6.87 | 9.18 | 12.61 | 14.2 |
Total Liabilities & Equity | 13.84 | 14.2 | 14.71 | 14.97 | 16.37 | 16.77 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3.91 | 3.71 | 2.53 | 1.39 | - | - |
Net Cash (Debt) | -3.91 | -3.71 | -2.53 | -1.39 | 0.51 | 0.08 |
Net Cash Growth | - | - | - | - | 556.50% | - |
Net Cash Per Share | -0.06 | -0.05 | -0.04 | -0.02 | 0.01 | 0.00 |
Filing Date Shares Outstanding | 67.98 | 67.98 | 67.98 | 67.98 | 67.98 | 67.98 |
Total Common Shares Outstanding | 67.98 | 67.98 | 67.98 | 67.98 | 67.98 | 67.98 |
Working Capital | -0.52 | 1.02 | -0.68 | -1.5 | -1.01 | -0 |
Book Value Per Share | 0.08 | 0.08 | 0.10 | 0.13 | 0.19 | 0.21 |
Tangible Book Value | 5.08 | 5.64 | 6.78 | 9.02 | 11.08 | 12.22 |
Tangible Book Value Per Share | 0.07 | 0.08 | 0.10 | 0.13 | 0.16 | 0.18 |
Land | - | 0.52 | 0.52 | 0.52 | 0.52 | 0.52 |
Buildings | - | 5.06 | 5.06 | 5.06 | 5.06 | 5.06 |
Machinery | - | 9.01 | 9.01 | 9.01 | 8.11 | 7.34 |